and Alpha (a division of Prime, Knutsford, UK), funded by Regeneron Pharmaceuticals, Inc., according to Good Publication Practice guidelines ( The authors were responsible for all content and editorial decisions, and received no honoraria related to the development of this publication
Discard it after 28 days regardless of how it looks
In clinical studies, the average weight loss was 15% and 20% with 77% of patients seeing sustained results for 2 years* *In a 68- and 72-week clinical trial studying Semaglutide in patients without diabetes and with BMI 30, or BMI 27 with a weight-related condition, the average weight loss was 15% and 20%, when paired with diet and exercise changes (compared to 2.4% and 3.1%, respectively, with diet and exercise alone)
95% CI, 1.23 to 1.52) [39]
[DOI] [PubMed] [Google Scholar] 627.Pop-Busui R, Backlund JC, Bebu I, et al